Showing 581-590 of 2400 results for "".
Cryptogenic Stroke & Atrial Fibrillation: Establishing the Link Through Team Approaches to Care
https://practicalneurology.com/diseases-diagnoses/stroke/cryptogenic-stroke--atrial-fibrillation-establishing-the-link-through-team-approaches-to-care/30393/Implementing a Cryptogenic Stroke Pathway may help reduce recurrent strokes and improve outcomes for stroke patients.Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/alpha-synuclein-a-therapeutic-target-and-potential-biomarker-in-parkinsons-disease/30407/Comprehensive Stroke Certification What Does Does it Take?
https://practicalneurology.com/diseases-diagnoses/stroke/comprehensive-stroke-certification-what-does-does-it-take/30704/The Ochsner Medical Center ExperienceTics and Tourette Syndrome
https://practicalneurology.com/diseases-diagnoses/child-neurology/tics-and-tourette-syndrome/30330/Recognizing the full spectrum of phenomenology of tics and various behavioral comorbidities is critical to diagnosis.A Survey of Neurologists on Career Satisfaction and Burnout
https://practicalneurology.com/columns/practice-management/a-survey-of-neurologists-on-career-satisfaction-and-burnout/30707/Onabotulinumtoxin in the Preventive Treatment of Chronic Migraine and Other Headaches
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-in-the-preventive-treatment-of-chronic-migraine-and-other-headaches/30833/While BoNTA shows promise in the management of chronic migraine, optimal outcomes will be acheived when clinicians learn which patients are most likely to benefit.The Health Care Debate: What Will It Mean For You?
https://practicalneurology.com/columns/practice-management/PN0909_01-php/30887/The changes proposed in Congress could mean big changes to your practice. We take a look at how things could play out.COVID-19 & Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/covid-19-stroke/31740/COVID-19 has brought significant changes in stroke presentations, systems of care, and resource availability.Movement Disorders Moment: Incorporating Lifestyle Medicine Into Parkinson Disease Care—Evidence and Guidance for Clinical Practice
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-incorporating-lifestyle-medicine-into-parkinson-disease-care-evidence-and-guidance-for-clinical-practice/32196/Lifestyle medicine strategies play an important role in managing Parkinson disease and empowering patients and their care partners.Spinal Muscular Atrophy
https://practicalneurology.com/diseases-diagnoses/child-neurology/spinal-muscular-atrophy/31554/A devastating disease now has 2 approved breakthrough treatments available.